MedPath

Effect of combined probiotic and vitamin D supplementation in treatment of coronary heart disease

Phase 3
Conditions
Coronary Heart Disease.
Chronic ischaemic heart disease, unspecified
I25.9
Registration Number
IRCT2017073033941N4
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Subjects aged 45-85 years
Diagnosed with type 2 diabetes and CHD

Exclusion Criteria

Taking vitamin D, probiotic and/or synbiotic within the last 3 months
Patients with thyroid disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath